Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 210 participants.

Also called NCT07563673

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07563673
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07563673. Randomized; no masking; primary purpose treatment. Start 2026-05-01 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC)
Acronym
ELASTIC
Condition
Cerebral Infarction
Condition
Thrombolysis
Intervention (Drug)
Aspirin (Early, 2h)
Intervention (Drug)
Aspirin (Standard, 24h)
Lead sponsor
Beijing Chao Yang Hospital (class: other)

Record details

Record id
cardio:ct-nct07563673
Content hash
0df90fc4df4416606f918dfc1e26c60acbe708c452c3e40dd3043ea6063b5f11